OraSure Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
2018年11月8日 - 8:00PM
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of
care diagnostic tests and specimen collection devices, today
announced that Stephen S. Tang, Ph.D., President and CEO, will
speak to the investment community at the Canaccord Genuity Medical
Technologies & Diagnostics Forum. The conference will be
simultaneously webcast over the Internet.
Dr. Tang is scheduled to speak on November 15,
2018, at approximately 1:00 PM Eastern Time (10:00 AM Pacific
Time). Interested investors can access the live webcast of
the presentation by going to OraSure Technologies’ web site,
www.orasure.com, and clicking on the Investor Info link. A
replay of the webcast will be available on OraSure Technologies’
web site for seven days. Alternatively, you can access the
live webcast of the presentation via the following link:
http://wsw.com/webcast/canaccord32/osur/.
About OraSure
Technologies
OraSure Technologies is a leader in the
development, manufacture and distribution of point of care
diagnostic and collection devices and other technologies designed
to detect or diagnose critical medical conditions. Its
first-to-market, innovative products include rapid tests for the
detection of antibodies to HIV and HCV on the OraQuick® platform,
oral fluid sample collection, and stabilization and preparation
products for molecular diagnostic applications, and oral fluid
laboratory tests for detecting various drugs of abuse. OraSure's
portfolio of products is sold globally to various clinical
laboratories, hospitals, clinics, community-based organizations and
other public health organizations, research and academic
institutions, distributors, government agencies, physicians'
offices, commercial and industrial entities and consumers. The
Company's products enable healthcare providers to deliver critical
information to patients, empowering them to make decisions to
improve and protect their health. For more information on
OraSure Technologies, please visit www.orasure.com.
Company contact:
Roberto Cuca |
Jeanne Mell |
Chief Financial
Officer |
VP
Corporate Communications |
610-882-1820 |
610-882-1820 |
|
|
Investorinfo@orasure.com |
media@orasure.com |
www.orasure.com |
www.orasure.com |
OraSure Technologies (NASDAQ:OSUR)
過去 株価チャート
から 6 2024 まで 7 2024
OraSure Technologies (NASDAQ:OSUR)
過去 株価チャート
から 7 2023 まで 7 2024